Literature DB >> 24685681

Cytoskeleton and CFTR.

Aleksander Edelman1.   

Abstract

Cystic Fibrosis Transmembrane conductance Regulator, CFTR, is a membrane protein expressed in epithelia. A protein kinase A (PKA)-regulated Cl(-) channel, it is a rate-limiting factor in fluid transport. Mutations in CFTR are responsible for cystic fibrosis, CF, an autosomal recessive disease. The most frequent mutation is deletion of phenylalanine at position 508, ΔF508. The regulation of trafficking and degradation of CFTR/ΔF508CFTR as well as its function(s) is a complex process which involves a number of proteins including chaperones and adaptors. It is now known that cytoskeletal proteins, previously considered only as structural proteins, are also important factors in the regulation of cellular processes and functions. The aim of the present review is to focus on how microfilaments, microtubules and intermediary filaments form a dynamic interactome with CFTR to participate in the regulation of CFTR-dependent transepithelial ion transport, CFTR trafficking and degradation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Intermediary filaments; Keratin 8; Microfilaments; Microtubules

Mesh:

Substances:

Year:  2014        PMID: 24685681     DOI: 10.1016/j.biocel.2014.03.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

1.  Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015.

Authors:  Alan S Verkman; Aleksander Edelman; Margarida Amaral; Marcus A Mall; Jeffrey M Beekman; Torsten Meiners; Luis J V Galietta; Christine E Bear
Journal:  J Cyst Fibros       Date:  2015-10-21       Impact factor: 5.482

2.  Truncating Mutations in the Adhesion G Protein-Coupled Receptor G2 Gene ADGRG2 Cause an X-Linked Congenital Bilateral Absence of Vas Deferens.

Authors:  Olivier Patat; Adrien Pagin; Aurore Siegfried; Valérie Mitchell; Nicolas Chassaing; Stanislas Faguer; Laetitia Monteil; Véronique Gaston; Louis Bujan; Monique Courtade-Saïdi; François Marcelli; Guy Lalau; Jean-Marc Rigot; Roger Mieusset; Eric Bieth
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

3.  New insights into interactions between the nucleotide-binding domain of CFTR and keratin 8.

Authors:  Aiswarya Premchandar; Anna Kupniewska; Arkadiusz Bonna; Grazyna Faure; Tomasz Fraczyk; Ariel Roldan; Brice Hoffmann; Mélanie Faria da Cunha; Harald Herrmann; Gergely L Lukacs; Aleksander Edelman; Michał Dadlez
Journal:  Protein Sci       Date:  2017-02       Impact factor: 6.725

4.  Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

5.  Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS.

Authors:  Debora Baroni; Olga Zegarra-Moran; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2014-10-02       Impact factor: 9.261

6.  Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.

Authors:  Hong Dang; Deepika Polineni; Rhonda G Pace; Jaclyn R Stonebraker; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Wanda K O'Neal; Michael R Knowles
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

7.  CFTR channel in oocytes from Xenopus laevis and its regulation by xShroom1 protein.

Authors:  Alejandra G Palma; Luciano Galizia; Basilio A Kotsias; Gabriela I Marino
Journal:  Pflugers Arch       Date:  2016-02-18       Impact factor: 3.657

8.  Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.

Authors:  Elizabeth R Peitzman; Nathan A Zaidman; Peter J Maniak; Scott M O'Grady
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-13       Impact factor: 5.464

Review 9.  Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

Authors:  Margarida D Amaral; William E Balch
Journal:  J Cyst Fibros       Date:  2015-10-29       Impact factor: 5.482

10.  In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.

Authors:  Pascal Trouvé; Emmanuelle Génin; Claude Férec
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.